1. An implicit understanding of research
Our approach is research led and we have a proven commitment to supporting medical progress through several research funds.
2. Exceptional resources
Our robust blend of technical, regulatory,
3. A history of success
We have an impressive track record in successfully commercialising medical innovations such as INOmax® for pulmonary hypertension in neonates.
4. A remarkable reach
We have a global presence with operations in 50 countries including the key growth centres of China and India.
5. A comprehensive clinical presence
We are present across healthcare, including hospital, critical care, intermediate therapy and home care.